Citigroup Maintains Neutral on Qiagen, Raises Price Target to $45
Benzinga Newsdesk 2 months ago
NewsPrice TargetAnalyst Ratings
Citigroup analyst Brendan Digan maintains Qiagen (NYSE:QGEN) with a Neutral and raises the price target from $38 to $45.
Citigroup analyst Brendan Digan maintains Qiagen (NYSE:QGEN) with a Neutral and raises the price target from $38 to $45.